466 related articles for article (PubMed ID: 28925794)
41. Spray dried human and chimpanzee adenoviral-vectored vaccines are thermally stable and immunogenic in vivo.
Afkhami S; LeClair DA; Haddadi S; Lai R; Toniolo SP; Ertl HC; Cranston ED; Thompson MR; Xing Z
Vaccine; 2017 May; 35(22):2916-2924. PubMed ID: 28438408
[TBL] [Abstract][Full Text] [Related]
42. Effect of thermal and shear stresses in the spray drying process on the stability of siRNA dry powders.
Wu J; Wu L; Wan F; Rantanen J; Cun D; Yang M
Int J Pharm; 2019 Jul; 566():32-39. PubMed ID: 31077763
[TBL] [Abstract][Full Text] [Related]
43. Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures.
Geeraedts F; Saluja V; ter Veer W; Amorij JP; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A
AAPS J; 2010 Jun; 12(2):215-22. PubMed ID: 20195930
[TBL] [Abstract][Full Text] [Related]
44. Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry.
Huyge K; Van Reeth K; De Beer T; Landman WJ; van Eck JH; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2012 Apr; 80(3):649-56. PubMed ID: 22155763
[TBL] [Abstract][Full Text] [Related]
45. A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.
Li X; Thakkar SG; Ruwona TB; Williams RO; Cui Z
J Control Release; 2015 Apr; 204():38-50. PubMed ID: 25735896
[TBL] [Abstract][Full Text] [Related]
46. Stabilization of HSV-2 viral vaccine candidate by spray drying.
LeClair DA; Li L; Rahman N; Cranston ED; Xing Z; Thompson MR
Int J Pharm; 2019 Oct; 569():118615. PubMed ID: 31415872
[TBL] [Abstract][Full Text] [Related]
47. Spray-drying nanocapsules in presence of colloidal silica as drying auxiliary agent: formulation and process variables optimization using experimental designs.
Tewa-Tagne P; Degobert G; Briançon S; Bordes C; Gauvrit JY; Lanteri P; Fessi H
Pharm Res; 2007 Apr; 24(4):650-61. PubMed ID: 17318421
[TBL] [Abstract][Full Text] [Related]
48. Bacteriophage Encapsulation Using Spray Drying for Phage Therapy.
Malik DJ
Curr Issues Mol Biol; 2021; 40():303-316. PubMed ID: 32678066
[TBL] [Abstract][Full Text] [Related]
49. Optimization of Spray Drying Conditions for Yield, Particle Size and Biological Activity of Thermally Stable Viral Vectors.
LeClair DA; Cranston ED; Xing Z; Thompson MR
Pharm Res; 2016 Nov; 33(11):2763-76. PubMed ID: 27450412
[TBL] [Abstract][Full Text] [Related]
50. Formulation and performance of danazol nano-crystalline suspensions and spray dried powders.
Kumar S; Jog R; Shen J; Zolnik B; Sadrieh N; Burgess DJ
Pharm Res; 2015 May; 32(5):1694-703. PubMed ID: 25385690
[TBL] [Abstract][Full Text] [Related]
51. Protein powders for encapsulation: a comparison of spray-freeze drying and spray drying of darbepoetin alfa.
Nguyen XC; Herberger JD; Burke PA
Pharm Res; 2004 Mar; 21(3):507-14. PubMed ID: 15070103
[TBL] [Abstract][Full Text] [Related]
52. Spray Drying and Particle Engineering in Dosage Form Design for Global Vaccines.
Gomez M; Vehring R
J Aerosol Med Pulm Drug Deliv; 2022 Jun; 35(3):121-138. PubMed ID: 35172104
[TBL] [Abstract][Full Text] [Related]
53. The effect of operating and formulation variables on the morphology of spray-dried protein particles.
Maa YF; Costantino HR; Nguyen PA; Hsu CC
Pharm Dev Technol; 1997 Aug; 2(3):213-23. PubMed ID: 9552449
[TBL] [Abstract][Full Text] [Related]
54. Stabilization of IgG1 in spray-dried powders for inhalation.
Schüle S; Schulz-Fademrecht T; Garidel P; Bechtold-Peters K; Frieb W
Eur J Pharm Biopharm; 2008 Aug; 69(3):793-807. PubMed ID: 18477504
[TBL] [Abstract][Full Text] [Related]
55. Redispersible spray-dried lipid-core nanocapsules intended for oral delivery: the influence of the particle number on redispersibility.
Andrade DF; Vukosavljevic B; Benvenutti EV; Pohlmann AR; Guterres SS; Windbergs M; Beck RCR
Pharm Dev Technol; 2018 Apr; 23(4):414-425. PubMed ID: 29095657
[TBL] [Abstract][Full Text] [Related]
56. Preparation and solidification of redispersible nanosuspensions.
Zhang X; Guan J; Ni R; Li LC; Mao S
J Pharm Sci; 2014 Jul; 103(7):2166-2176. PubMed ID: 24840928
[TBL] [Abstract][Full Text] [Related]
57. Development of a dried influenza whole inactivated virus vaccine for pulmonary immunization.
Audouy SA; van der Schaaf G; Hinrichs WL; Frijlink HW; Wilschut J; Huckriede A
Vaccine; 2011 Jun; 29(26):4345-52. PubMed ID: 21514345
[TBL] [Abstract][Full Text] [Related]
58. Development of directly compressible powders via co-spray drying.
Gonnissen Y; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2007 Aug; 67(1):220-6. PubMed ID: 17317123
[TBL] [Abstract][Full Text] [Related]
59. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
Yu H; Teo J; Chew JW; Hadinoto K
Int J Pharm; 2016 Feb; 499(1-2):38-46. PubMed ID: 26757148
[TBL] [Abstract][Full Text] [Related]
60. The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process.
Grohganz H; Lee YY; Rantanen J; Yang M
Int J Pharm; 2013 Apr; 447(1-2):224-30. PubMed ID: 23500620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
